Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,096 | -100,430 | -66,440 | -33,266 | -142,094 |
| Depreciation Amortization | 8,458 | 6,354 | 3,906 | 1,662 | 5,658 |
| Income taxes - deferred | -72 | 348 | 115 | -280 | -1,344 |
| Accounts payable and accrued liabilities | -1,816 | -783 | -1,286 | 1,085 | 1,439 |
| Other Working Capital | 4,138 | -17,771 | -12,828 | -5,472 | 1,410 |
| Other Operating Activity | 13,527 | 3,579 | 2,579 | -1,072 | 17,173 |
| Operating Cash Flow | $-117,861 | $-108,703 | $-73,954 | $-37,343 | $-117,758 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,857 | -7,272 | -3,411 | -1,900 | -14,681 |
| Investing Cash Flow | $-8,857 | $-7,272 | $-3,411 | $-1,900 | $-14,681 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 246,025 | 136,648 | 136,878 | 130,897 | 80,212 |
| Other Financing Activity | 38,038 | 0 | 0 | -7,573 | -5,797 |
| Financing Cash Flow | $284,063 | $136,648 | $136,878 | $123,324 | $74,415 |
| Exchange Rate Effect | -754 | -1,488 | 2,964 | 1,632 | 679 |
| Beginning Cash Position | 154,085 | 154,085 | 154,085 | 154,085 | 211,430 |
| End Cash Position | 310,676 | 173,270 | 216,562 | 239,798 | 154,085 |
| Net Cash Flow | $156,591 | $19,185 | $62,477 | $85,713 | $-57,345 |
| Free Cash Flow | |||||
| Operating Cash Flow | -117,861 | -108,703 | -73,954 | -37,343 | -117,758 |
| Capital Expenditure | -8,857 | -7,272 | -3,411 | -1,900 | -14,681 |
| Free Cash Flow | -126,718 | -115,975 | -77,365 | -39,243 | -132,439 |